Metformin directly inhibits androgen production in human thecal cells.
about
Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indicationsMetformin treatment before and during IVF or ICSI in women with polycystic ovary syndromeMetformin treatment before and during IVF or ICSI in women with polycystic ovary syndromeInsulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycleThe therapy of insulin resistance in other diseases besides type 2 diabetesPrenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthoodAndrogen receptor antagonism and an insulin sensitizer block the advancement of vaginal opening by high-fat diet in mice.The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma.Testosterone improves the differentiation efficiency of insulin-producing cells from human induced pluripotent stem cells.Pharmacotherapy of polycystic ovary syndrome--an update.Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial.The effect of metformin treatment in vivo on acute and long-term energy metabolism and progesterone production in vitro by granulosa cells from women with polycystic ovary syndromeDiverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies.Impact of metformin on reproductive tissues: an overview from gametogenesis to gestationClomiphene citrate--end of an era? A mini-review.Metformin and polycystic ovary syndrome.Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatmentPolycystic ovary syndrome: chemical pharmacotherapy.Reversing the reduced level of endometrial GLUT4 expression in polycystic ovary syndrome: a mechanistic study of metformin action.Metformin: direct inhibition of rat ovarian theca-interstitial cell proliferation.The effects of old, new and emerging medicines on metabolic aberrations in PCOS.Role of metformin in the management of polycystic ovary syndrome.Clomiphene citrate, metformin or a combination of both as the first line ovulation induction drug for Asian Indian women with polycystic ovarian syndrome: A randomized controlled trialComparison of Metformin and Simvastatin Administration in Women With Polycystic Ovary Syndrome Before Intra-Cytoplasmic Sperm Injection Cycle: A Prospective, Randomized, Clinical Trial StudyMetformin therapy decreases hyperandrogenism and ovarian volume in women with polycystic ovary syndromeCirculatory estrogen level protects against breast cancer in obese women.Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.Androgen circle of polycystic ovary syndrome.Serum leptin changes with metformin treatment in polycystic ovarian syndrome: correlation with ovulation, insulin and testosterone levels.Female adipocyte androgen synthesis and the effects of insulinAmeliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats.Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.The metabolic effects of drugs used for the treatment of polycystic ovary syndromeEffects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials.Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome.Metformin Suppresses Prostaglandin E2-Induced Cytochrome P450 Aromatase Gene Expression and Activity via Stimulation of AMP-Activated Protein Kinase in Human Endometriotic Stromal Cells.
P2860
Q22242884-F7BA30B3-BF01-4A94-A14F-DD39F093DCC6Q24187959-38692BDF-9364-474E-9684-1156EF744520Q24241022-DC1AD449-C9A0-4BA2-AB9B-0E74B6433078Q26745509-4619D622-8853-4C4A-BD81-27B99CE0BDA9Q26822399-D2750861-C69D-46A2-9177-11BDF3BC815FQ30428511-0C904049-91FC-40FE-BF13-2FFE92981838Q30433940-033D0945-2024-41AD-AC34-07C3396EF312Q30440354-61AE4A1D-ABC7-4441-90EB-76BF158B5197Q33569099-5E913F7C-CF73-4001-AD08-F96FEA6DDF18Q33569169-B7EF33FC-A214-4BE3-856E-5360BE0F56EDQ33675285-108E78C7-DB31-4E7C-95F3-C9F5BCBC9F8AQ33778800-0D07C7A2-974E-4ABD-84AC-6A3A59364939Q33787190-1B6C23C4-7590-4E38-9303-92F88D1D2B50Q33937651-C6BDE7D3-0591-42C1-A2A9-CE7524FFB550Q34181502-6F0CDD23-7CF4-4D43-9CE7-861DF53D5D11Q34198265-4FF5DB9B-16D4-4CAA-ADDB-BA86FEC8BB7AQ34357928-7E1F00C4-4110-494F-9EF2-9061CE88A1F8Q34557430-DFA20A6B-8624-4ABD-ACDA-6554EF9E6006Q34746925-5345B53E-5300-4E75-A9F4-9DD44268EE87Q35497969-B7CAAD5F-2BCA-4BF8-8540-F57831EE06AFQ35639510-8A49BAA0-B7AC-4725-AAD5-82EF2422C55CQ35662997-4C16AD46-F9CC-43FE-962E-6C54C25798FEQ36074452-6DB90EF2-7B7A-4537-AB57-64986D40F561Q36328060-A55CD762-2300-4A12-8D9E-BB281C65B65AQ36329913-07ABFB17-953E-4A1C-A450-6F12B481955DQ36406468-B9D6E839-6EE0-468A-9FFA-2E7C6CCA5A8DQ36446425-432FEFFA-1E6C-49B4-8C99-ED033434D7AEQ36567067-7817C19A-F250-40F3-9876-982EB6A103A5Q36795622-26CCAF18-B6CC-4682-ADA8-E64022C5087EQ37071255-754B8695-AC60-4EA0-A136-CC5C15E490CAQ37412808-D27890D2-1E51-47FC-B468-0C8E20CDB37DQ37413811-9AA6320E-5374-4C57-AB9F-FE75DD71CE13Q37434161-16506D9B-7A06-4046-9674-8DCB61CF96C9Q37480891-A02201ED-1B14-4752-9F4F-AA7B19138E44Q37570577-4C0BDC92-3A62-4F78-AA80-6DF2337DFE54Q37591848-51DFAF83-4276-4847-BEDE-84BEC5574781Q38063567-3D3085F0-771F-4AED-8797-A7F2590D3E08Q38211907-09289DA3-B166-4F58-B751-5371055D0DACQ38950805-7A7610FA-1664-4BBD-AE2E-A05ACC65098AQ38997590-F7E445E2-638D-4FA0-B65B-B2B8A1398B8A
P2860
Metformin directly inhibits androgen production in human thecal cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Metformin directly inhibits androgen production in human thecal cells.
@en
Metformin directly inhibits androgen production in human thecal cells.
@nl
type
label
Metformin directly inhibits androgen production in human thecal cells.
@en
Metformin directly inhibits androgen production in human thecal cells.
@nl
prefLabel
Metformin directly inhibits androgen production in human thecal cells.
@en
Metformin directly inhibits androgen production in human thecal cells.
@nl
P2093
P1476
Metformin directly inhibits androgen production in human thecal cells.
@en
P2093
P304
P356
10.1016/S0015-0282(01)01975-6
P407
P577
2001-09-01T00:00:00Z